Medical Devices Europe

Europe Smart Inhalers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Smart Inhalers Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $50.9 Mn Placeholder estimate
Estimate 2025 $60.6 Mn 21% of the global market
Projected 2034 $290.0 Mn 378.5% Adds $229.4 Mn over 9 forecast years
CAGR 2025–2034 19.0% Faster than 95% of 173 Medical Devices markets here
Key players 5
  • Europe is 21.04% of the global market.
  • Among regions, the largest is North America at $137.1 Mn.
  • Fastest growing: APAC at 21.4% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$229.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smart Inhalers Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $50.9 Mn — —
2025 (base) $60.6 Mn +$9.7 Mn —
2026 (forecast) $72.1 Mn +$11.5 Mn +19%
2027 (forecast) $85.8 Mn +$13.7 Mn +41.6%
2028 (forecast) $102.1 Mn +$16.3 Mn +68.5%
2029 (forecast) $121.5 Mn +$19.4 Mn +100.5%
2030 (forecast) $144.6 Mn +$23.1 Mn +138.6%
2031 (forecast) $172.1 Mn +$27.5 Mn +184%
2032 (forecast) $204.8 Mn +$32.7 Mn +237.9%
2033 (forecast) $243.7 Mn +$38.9 Mn +302.1%
2034 (forecast) $290.0 Mn +$46.3 Mn +378.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Smart Inhalers Market Analysis at a glance
Market size, 2025$60.6 Mn placeholder estimate
Forecast, 2034$290.0 Mn placeholder estimate
Growth (CAGR), 2025–203419.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersPropeller Health, Adherium, Teva Pharmaceutical, AstraZeneca, Cohero Health (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Smart Inhalers Market Analysis Executive Summary

Smart inhalers record when and how a patient uses an inhaler and send reminders, helping control asthma and COPD.

Key segments of the smart Inhalers market include product (Inhaler Add-On Sensors and Integrated Smart Inhalers) and indication (Asthma and COPD).

Bar chart: Europe Smart Inhalers market size, 2024–2034, placeholder estimates. $50.9 Mn in 2024, $60.6 Mn in 2025 and $290.0 Mn in 2034, 19.0% CAGR.
Europe Smart Inhalers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Smart Inhalers Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the smart Inhalers market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the smart Inhalers market.

Competitive Landscape for Smart Inhalers Market in Europe

The smart Inhalers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smart Inhalers Market in Europe

Smart Inhalers in Europe: rules and payment

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how smart Inhalers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smart Inhalers right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smart Inhalers in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smart Inhalers market in Europe?
Placeholder estimate: about $60.6 Mn in 2025, rising to about $290.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smart Inhalers market in Europe growing?
Placeholder estimate: about 19.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smart Inhalers market report cover?
The report splits the market by product (Inhaler Add-On Sensors, Integrated Smart Inhalers), indication (Asthma, COPD) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Smart Inhalers market?
Key players include Propeller Health, Adherium, Teva Pharmaceutical, AstraZeneca and Cohero Health.
What is driving the Smart Inhalers market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.
Who regulates Smart Inhalers in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How much research is published on Smart Inhalers?
PubMed lists 47 papers on Smart Inhalers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on respiratory and remote monitoring and wearables

See the topic